Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

  • Dansk
  • NL
  • EN
  • FI
  • FR
  • DE
  • EL
  • IT
  • NO
  • PL
  • PT
  • RO
  • SL
  • ES
  • SV

Conflicts of interest EFSA board letter

Corporate Europe Observatory (CEO) last week highlighted in a report that at least four members of EFSA’s management board are employed by or otherwise linked with food industry lobby groups and other commercial interests, a situation that creates potential conflicts of interest. These board members are: Matthias Horst (director general of the German food industry lobby BVE), Milan Kováč (director of International Life Sciences Institute Europe), Jiří Ruprich (Danone Institute) and Piet Vanthemsche (farmers’ lobby COPA and Agri Investment Fund).

EFSA’s press officer responded by arguing that according to EFSA’s Founding Regulation, four of the 15 Management Board members “shall have their background in organisations representing consumers and other interests in the food chain”. She said that these four members are currently Matthias Horst (industry), Piet Vanthemsche (farmers), Sue Davies (consumers) and Sinikka Turunen (consumers).

CEO does not find such a justification acceptable and reacts with an open letter.


LEt’s kick Big Oil and Gas out of EU and UN climate policy. sign the petition now!

The European Food Safety Authority (EFSA) told CEO today, and publicly announced on their website, that they would disclose most of the raw data of studies on glyphosate used in the EU's toxicity assessment of glyphosate.

The official EU assessment of glyphosate was based on unpublished studies owned by industry. Seven months later, the pesticide industry still fights disclosure and, so far, successfully. We obtained a copy of their arguments.

The European Commission proposal on scientific criteria defining endocrine disruptors (EDCs) is the latest dangerous outgrowth of a highly toxic debate. The chemical lobby, supported by certain Commission factions (notably DG SANTE and the Secretary-General) and some member states (UK and Germany), has put significant obstacles in the way of effective public health and environment regulation.

This May is dense on the EU chemicals regulation front. Crunch time for two major files: the European Commission needs to publish the identification criteria for endocrine disrupting chemicals, and together with EU States must decide how, or not, renew the market approval of glyphosate, an herbicide produced and defended by Monsanto. Last week, the Professor Alan Boobis happened to be involved in both.

As world leaders prepare for COP22 in Marrakesh, Morocco, this November, the oil and gas industry retains a firm grip on the UN climate talks and climate policy in general. It’s time to break free and reclaim power over climate policy.
The EU-Canada trade deal CETA continues to draw heavy criticism. Behind the PR attempts to sell it as a progressive agreement - including a recent declaration hammered out by Brussels and Ottawa - CETA remains what it always has been: an attack on democracy, workers, and the environment.
Corporations like Monsanto have limitless resources to buy political power through lobbying. This short guide, published at the occasion of the International Monsanto Tribunal in The Hague, exposes some of Monsanto’s key lobbying strategies and tools, illustrated with examples from different parts of the world.
How the agribusiness lobby has weakened the new EU air quality directive with serious consequences for health. An article written by Vincent Harmsen en Berna van Vilsteren and translated by Iris Maher.
-- placeholder --

The corporate lobby tour